Boston-based a2z Radiology raised $4.5M and earned FDA clearance for its Unified Triage AI solution for abdominal and pelvic CT scans.
Key Details
- 1a2z Radiology, founded in 2024, is developing AI tools for medical imaging interpretation.
- 2The company secured $4.5 million in seed funding from investors including SeaX and Khosla Ventures.
- 3Its Unified Triage system received FDA clearance and is designed as a multi-condition tool for abdomen-pelvis CT analysis.
- 4a2z claims its product is the first of its kind, focusing on broad multi-condition triage instead of single findings.
- 5The funds will be used to commercially deploy Unified Triage and develop further imaging AI products.
- 6Harvard biomedical informatics professor Pranav Rajpurkar co-founded the startup.
Why It Matters
Multi-condition AI tools could streamline radiology workflows, helping to detect a broader range of pathologies in a single scan and supporting radiologist efficiency. Regulatory milestones and investment indicate escalating momentum for generalist AI in medical imaging.
Source
Radiology Business
Related News
•AuntMinnie
AI Triage Tool Speeds Up ICH Head CT Turnaround in ED
AI-based triage for intracranial hemorrhage on head CT reduced emergency department report turnaround by 13 minutes.
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.
•Radiology Business
FDA Approves SimBioSys AI Tool for Breast Cancer Risk via MRI
SimBioSys received FDA clearance for TumorSight Risk, an AI tool assessing breast cancer recurrence risk using MRI.